Report Code: A13856 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Cancer profiling is an approach for more correctly classifying cancers and predicting a patient's clinical outcomes. Cancer/tumor profiling aids in the discovery of genetic alterations, which assists in the selection of appropriate cancer therapy. This technique eliminates the need for trial-and-error in cancer diagnosis at various stages and provides more precise and reliable information regarding cancer clinical outcomes.
Different procedures are used to diagnose cancer, including blood and urine tests, biopsy, imaging tests (X-ray, MRI, PET/CT, and ultrasound), nuclear medicine scans, and lumber puncture, which are unable to pinpoint the exact cause of cancer in the early stages. Overtreatment of cancer patients may result as a result of this. To provide better, customized treatment to the cancer patient, laboratory tests are performed to detect specific genes or gene mutations, proteins, or other biomarkers in a sample of tumor tissue.
COVID-19 Impact analysis
Top Impacting Factors
Rise in the incidence of cancer, population growth, and aging, as well as the changes in prevalence of certain causes of cancer linked to social and economic development, are the factors propelling cancer/tumor profiling market.
In addition, increased demand for personalized medicine and next-generation sequencing (NGS) technology is also expected to boost the growth of the Cancer Profiling and Pathways market.Â
Moreover, government funding for continuing research in tumor or cancer diagnostics and profiling is another major factor driving the growth of the market.
The rise in the adoption of cancer profiling methods by oncologists as well as an increase in the use of biomarkers in cancer profiling is projected to surge the Cancer Profiling and Pathways market growth.
An increase in the demand for next-generation sequencing techniques in cancer profiling is expected to boost the Cancer Profiling and Pathways market growth.Â
However, the large gap between the biomarker discovery stage and their clinical conversion is being hindered by challenges in conversion procedures.
Market Trends
New product launches to flourish the market
Key Benefits of the Report
Questions answered in the Cancer Profiling and Pathways Report
Cancer Profiling and Pathways Market Report Highlights
Aspects | Details |
---|---|
By Technology |
|
By Technique |
|
By Application |
|
By End User |
|
By Region |
|
Key Market Players | Neogenomics Inc., Qiagen N.V., Illumina Inc, Oxford Gene Technology, Foundation Medicine., GenomeDX, Nanostring Technologies, Ribomed Biotechnologies Inc., Guardant Health, Genomic Health |
Loading Table Of Content...
Start reading.
This Report and over 71,321+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers